Overview

Magnesium Sulfate as an Adjuvant to Propofol During Consious Sedation in Colonoscopy

Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
0
Participant gender:
All
Summary
Colonoscopy is one of the most commonly performed outpatient procedures throughout the world as a screening, diagnostic, and therapeutic tool to evaluate the large intestine from the distal rectum to the cecum.Propofol is the most commonly used hypnotic agent in sedation during endoscopic procedures for its advantages of fast onset and quick recovery. However, propofol may cause respiratory depression and cardiovascular events, which are easier to appear in cases of old age and high speed administration of propofol.Magnesium is a non-specific calcium channel inhibitor and a non-competitive N-methyl-D-aspartate(NMDA)receptor antagonist, which has analgesic and mild sedative properties .
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Assiut University
Treatments:
Magnesium Sulfate
Propofol
Criteria
Inclusion Criteria:

- 1. The subject is scheduled for elective colonoscopy. 2. The subject is ≥ 40 years and
≤ 70 years. 3. Both sexes. 4.No obvious abnormalities in preoperative ECG, blood
routine, electrolytes, and other tests. 5. ASA class 1-3.

Exclusion Criteria:

- 1.Subject is known or believed to be pregnant or lactating women. 2. Patients are
known hypersensitivity to any of the drugs that would be used in the study. 3. Severe
cardiac, renal, lung, or liver diseases. 4. Hypotension (systolic blood pressure< 90
mm Hg), uncontrolled hypertension (systolic blood pressure> 170 mmHg, diastolic blood
pressure> 100mmHg). 5. Chronic Opioid Use (daily or almost daily use of opioids for> 3
months). 6. Patients that are immunologically compromised. 7. Sleep apnea syndrome or
difficult airway. 8. preexisting hypoxemia (Spo2< 90 %). 9. History of adverse events
with prior sedation. Additionally, patients who had taken any sedative drugs within
the previous 24h